burns

Objective. To explore potential of anti-Pseudomonas vaccine for the prophylaxis and treatment of infections caused by Pseudomonas aeruginosa in patients with severe burn trauma. Materials and Methods. This was a pilot, singlecenter randomized, parallel group study which enrolled patients with burns involving 10 to 60% of the body surface area. A total of 24 patients have received a course of «Pseudovac» vaccine (vaccination group), and 24 patients were included in the control arm (non-vaccination group).

A total of 1375 clinical strains of staphylococci isolated from patients in burn units during the 2002–2008 were tested to detect antimicrobial resistance changes during this period. Antimicrobial susceptibility testing was performed by …